8-苯基-1,4-二噁螺[4.5]癸烷-8-甲胺 | 443687-93-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 8-苯基-1,4-二噁螺[4.5]癸烷-8-甲胺
• 中文别名: (8-苯基-1,4-二氧杂螺[4.5]癸烷-8-基)甲胺
• 英文名称: (8-phenyl-1,4-dioxaspiro[4.5]decan-8-yl)methanamine
• CAS: 443687-93-2
• 化学式: C₁₅H₂₁NO₂
• 分子量: 247.337
• InChiKey: IHVLVGYHVPQYKR-UHFFFAOYSA-N

物化性质

• 沸点：
  380.2±42.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  44.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2932999099

反应信息

• 作为反应物：
  描述：

  8-苯基-1,4-二噁螺[4.5]癸烷-8-甲胺 在 盐酸 作用下， 以 四氢呋喃 、 水 、 正丁醇 为溶剂， 生成
  参考文献：
  名称：

  Pseudosaccharin amines as potent and selective K V 1.5 blockers

  摘要：

  Phenethyl aminoheterocycles like compound 1 were known to be potent I-Kur blockers although they lacked potency in vivo. Modification of the heterocycle led to the design and synthesis of pseudosaccharin amines. Compounds such as 14, 17d and 21c were found to be potent K(V)1.5 blockers and selective over other cardiac ion channels. These compounds had potent pharmacodynamic activity, however, they also showed off-target activities such as hemodynamic effects. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.02.066
• 作为产物：
  描述：

  4-氰-4-苯基环己酮 在 lithium aluminium tetrahydride 、 对甲苯磺酸 作用下， 以 四氢呋喃 、 苯 为溶剂， 生成 8-苯基-1,4-二噁螺[4.5]癸烷-8-甲胺
  参考文献：
  名称：

  Pseudosaccharin amines as potent and selective K V 1.5 blockers

  摘要：

  Phenethyl aminoheterocycles like compound 1 were known to be potent I-Kur blockers although they lacked potency in vivo. Modification of the heterocycle led to the design and synthesis of pseudosaccharin amines. Compounds such as 14, 17d and 21c were found to be potent K(V)1.5 blockers and selective over other cardiac ion channels. These compounds had potent pharmacodynamic activity, however, they also showed off-target activities such as hemodynamic effects. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.02.066

文献信息

• SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES
  申请人：NOLTE Bert

  公开号：US20090247530A1

  公开（公告）日：2009-10-01

  The invention relates to compounds that have an affinity to the μ-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions.

  这项发明涉及具有与μ-阿片受体和ORL 1-受体亲和力的化合物，其生产方法，含有这些化合物的药物以及利用这些化合物治疗疼痛和其他疾病的用途。
• Benzamide potassium channel inhibitors
  申请人：Merck & Co., Inc.

  公开号：US06194458B1

  公开（公告）日：2001-02-27

  This invention relates to benzamide potassium channel inhibitors of general structural Formula I. The compounds of this invention are useful in the treatment of autoimmune diseases, the prevention of rejection of foreign organ transplants and related afflictions, diseases and illnesses, and cardiac arrhythmias. Also within the scope of this invention are pharmaceutical formulations comprising a compound of Formula I and a pharmaceutical carrier, as well as pharmaceutical formulations comprising a compound of Formula I, one or more immunosuppressive compounds and a pharmaceutical carrier.

  这项发明涉及一般结构式I的苯甲酰胺钾通道抑制剂。 该发明的化合物在治疗自身免疫疾病、预防外源器官移植排斥和相关疾病、疾病和疾病以及心律失常方面具有用途。该发明范围还包括包含Formula I化合物和药用载体的药物配方，以及包含Formula I化合物、一种或多种免疫抑制化合物和药用载体的药物配方。
• Fused heterocyclic compounds
  申请人：Johnson A. James

  公开号：US20050250783A1

  公开（公告）日：2005-11-10

  A compound of formula I wherein m, n, A, B, D, E, G, H, Y, R 1 , R 2 , R 3 , R 4 , R 5 , and R 8 , are described herein.

  其中m、n、A、B、D、E、G、H、Y、R1、R2、R3、R4、R5和R8在本发明中有所描述。
• Carbocyclic potassium channel inhibitors
  申请人：Merck & Co., Inc.

  公开号：US06632836B1

  公开（公告）日：2003-10-14

  The present invention relates to a class of carbocyclic compounds of Formula I that are useful as potassium channel inhibitors to treat autoimmune disorders, cardiac arrhythmias, and the like.

  本发明涉及一类具有式I结构的碳环化合物，这些化合物可作为钾通道抑制剂，用于治疗自身免疫性疾病、心律失常等病症。
• CYCLOALKYL INHIBITORS OF POTASSIUM CHANNEL FUNCTION
  申请人：Lloyd John

  公开号：US20070142333A1

  公开（公告）日：2007-06-21

  Novel cycloalkyl compounds useful as inhibitors of potassium channel function (especially inhibitors of the K v 1 subfamily of voltage gated K + channels, especially inhibitors K v 1.5 which has been linked to the ultra-rapidly activating delayed rectifier K + current I Kur ), methods of using such compounds in the prevention and treatment of arrhythmia and I Kur -associated conditions, and pharmaceutical compositions containing such compounds.

  新型环烷基化合物可作为钾通道功能抑制剂使用（特别是钾离子电压门控K+通道的Kv1亚家族的抑制剂，特别是与超快速激活延迟整流K+电流IKur相关的Kv1.5抑制剂），使用这种化合物预防和治疗心律失常和IKur相关疾病的方法，以及含有这种化合物的药物组合物。